May & Baker Nigeria Plc has signed a manufacturing agreement with Sanofi Nigeria Limited, a subsidiary of the French pharmaceutical giant Sanofi.
Under the agreement, May & Baker Nigeria will use its World Health Organisation (WHO)-certified manufacturing facility to produce four product brands of Sanofi for sale in Nigeria and the West African market.
The products which May & Baker Nigeria will manufacture for Sanofi include Flagyl tablets and Suspension and Tarivid tablets, anti-infective medicines and Malareich tablets, an anti-malaria drug.
Industry analysts saw the agreement as a direct response to the call by the National Agency for Food and Drugs Administration and Control (NAFDAC) for pharmaceutical brand owners to localise their production by using locally available capacity to produce quality products in Nigeria.
The agreement was signed by Sanofi’s General Manager and Country Chair Nigeria – Ghana, Mrs. Folake Odediran and Managing Director, May & Baker Nigeria Plc, Mr. Nnamdi Okafor.
The signing ceremony was witnessed by Ms. Valeria Saviano, Sanofi’s Head of Supply Chain Africa, Mr. Sam Ohuabunwa, President, Pharmaceutical Society of Nigeria (PSN), Prof. Mojisola Adeyeye, Director General of NAFDAC represented by Dr. Monica Eimunjeze, a director in NAFDAC, Mr. Femi Soremekun President of NIROPHARM, and Mr. Frank Monumeh, Executive Secretary, Pharmaceutical Manufacturing Group of the Manufacturers Association of Nigeria (PMG-MAN), among other dignitaries in the healthcare industry.
Source: The Nation